The Native Antigen Company, one of the world’s leading suppliers of reagents that enables research into vaccines and diagnostics for emerging and endemic infectious diseases, has announced the commercial introduction of its Novel Coronavirus antigens, derived from the emerging Wuhan strain. These recombinant proteins offer scientists high-quality reagents to support ongoing infectious disease research, and … Continue reading “Antigens developed to aid fightback against coronavirus”
Category: COVID-19 news
Resource centre hosting the latest news and views on COVID19/coronavirus from BHP member organisations. Bookmark this page to easily access stories on our research, testing, analysis and good news stories.